APEX1 inhib 
Welcome,         Profile    Billing    Logout  
  Companies    Products    Diseases    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
APX3330 / Apexian, Ocuphire Pharma
ZETA-1, NCT04692688: Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy

Recruiting
2
100
US
APX3330, Placebo
Ocuphire Pharma, Inc.
Diabetic Retinopathy, Diabetic Macular Edema, NPDR - Non Proliferative Diabetic Retinopathy, PDR - Proliferative Diabetic Retinopathy
12/22
12/22

Download Options